The Steering Committee advises the HPC Board of Directors with regard to scientific strategy, and fosters national and international visibility to attract outstanding scientific talents. The Steering Committee members contribute to the regular quality control/peer-selection of HPC principal investigator applications. They are instrumental in accelerating HPC's integration within the Munich-based, as well as international scientific community and amplify HPC's global ambition as an innovator-hub at the interface of bioengineering, biomedicine and bioinformatics.
Members of the Steering Committee
- Prof. Magdalena Götz, Institute of Stem Cell Research
- Prof. Stephan Herzig, Institute for Diabetes and Cancer
- Prof. Martin Hrabe de Angelis, Institute of Experimental Genetics
- Prof. Heiko Lickert, Institute of Diabetes and Regeneration Research
- Prof. Michael Sattler, Institute of Structural Biology
- Prof. Fabian Theis, Institute for Computational Biology
- Prof. Juliane Winkelmann, Institute for Neurogenomics
- Prof. Wolfgang Wurst, Institute of Developmental Genetics
- Prof. Eleftheria Zeggini, Institute for Translational Genomics
The Scientific Advisory Board (SAB) provides an objective and external perspective to HPC and ensures the quality and international standards of HPC’s scientific and institutional operations. Specifically, the SAB advises the HPC Board of Directors on emerging global scientific trends and research priorities. The SAB also contributes to HPC's international visibility, enables scientific collaborations and partnerships, and serves a crucial role in the peer-evaluation of HPC scientists at the time of contract renewals.
Members of the Scientific Advisory Board
- Prof. Steven Chu; Stanford University, Stanford, USA
- Prof. Amanda Fisher; MRC London Institute of Medical Sciences, London, UK
- Prof. Matthias Mann; Max Planck Institute of Biochemistry, Munich, Germany
- Prof. Stephen Quake; Stanford University and Chan Zuckerberg Biohub, USA
- Dr. Scott Sternson; HHMI - Janelia Research Campus, Ashburn, USA
Dr. Julia Groth
Julia obtained her PhD from the Ludwig Maximilians University Munich, studying rRNA gene transcription and epigenetics in the lab of Gernot Längst. Pursuing her interest in science management, she then engaged in the coordination of an EU-wide academic-corporate research project focusing on cancer and epigenetics at the LMU Munich. Julia took her next career step in California, where she worked as administrative coordinator for a translational cancer research program funded by the NCI/NIH at the University of California, Los Angeles. She joined the team in February 2018.
Dr. Manuela Hartmann
Manuela did her PhD in soil microbiology at the Technical University Munich, followed by a post-doc and subsequent long-term position as scientist at the National Oceanography Centre in Southampton (UK). She studied food web relations of single-cell organisms in the sea. In parallel, she engaged as lab manager and held responsibility for health and safety as well as radiation protection. Months-long research cruises taught her the value of excellent organisational and project management skills, a mix Manuela will contribute to accelerate HPC’s growth. Manuela joined the team in October 2018.
Dr. Andreas Schröder
Andreas received his PhD at the Max von Pettenkofer-Institute in Munich working on Staphylococcus aureus – human endothelial cell interaction. During his postdoc at the Mayo Clinic in Rochester, Minnesota, USA, he worked in the laboratory of Prof. Fergus Couch analyzing mutations in known breast cancer predisposition genes. Since September 2018, he is a member of the administrative team where he supports the HPC deployment as Technical Project Manager.